Podiatrist · Jacksonville, FL
NPI
1992723647
Since 2006
Specialty
Podiatrist
Code 213E00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
8262 Point Meadows Dr Ste 202
Jacksonville, FL, 32256
Phone (904) 265-0470
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
5,306 services
Medicare patients, 2024
464
Average age 73
Drug cost, 2024
$23K
636 prescriptions
Company payments, 2025
$2,283
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy M Syperek was code Q4164 (helicoll, per square centimeter), 1,193 times for 14 patients. In total Timothy M Syperek billed 5,306 services in 99 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q4164 Helicoll, per square centimeter | Office | 1,193 | 14 | $1,238.20 | $1.5M |
| 99214 Office E&M - Established | Office | 927 | 336 | $91.92 | $85K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 760 | 12 | $0.10 | $74.16 |
| 11721 Nail Procedure | Office | 510 | 205 | $32.70 | $17K |
| 11042 Debridement | Office | 365 | 165 | $90.96 | $33K |
| 11043 Debridement | Office | 242 | 37 | $171.51 | $42K |
| 15271 Skin and Soft Tissue Substitutes | Office | 210 | 21 | $66.11 | $14K |
| 73630 X-ray - Lower Extremity | Office | 209 | 140 | $25.83 | $5,399 |
| 99204 Office E&M - New | Office | 206 | 206 | $118.98 | $25K |
| 73600 X-ray - Lower Extremity | Office | 56 | 33 | $23.04 | $1,290 |
| 99231 Hospital E&M - Subsequent | Facility | 41 | 18 | $38.74 | $1,588 |
| 11750 Nail Procedure | Office | 29 | 26 | $99.73 | $2,892 |
| 11043 Debridement | Facility | 24 | 22 | $94.54 | $2,269 |
| 20600 Joint Injection | Office | 13 | 11 | $35.56 | $462 |
| 99213 Office E&M - Established | Office | 11 | 11 | $70.19 | $772 |
By year: 2022 $174K for 1,815 services; 2023 $708K for 2,087 services; 2024 $2.3M for 5,306 services.
Medicare prescription drug claims, 2024
In 2024, the drug Timothy M Syperek prescribed most often to Medicare patients was Terbinafine Hcl, with 212 prescriptions and refills. In total Timothy M Syperek wrote 636 Medicare prescriptions that cost $23K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Terbinafine Hcl Generic | 212 | 602 | 175 | $4,861 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 92 | 92 | 77 | $694 |
| Ciclopirox Generic | 68 | 68 | 52 | $1,964 |
| Meloxicam Generic | 68 | 78 | 57 | $159 |
| Dexamethasone Generic | 52 | 52 | 47 | $258 |
| Cephalexin Generic | 35 | 35 | 32 | $501 |
| Mupirocin Generic | 34 | 34 | 27 | $270 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 24 | 24 | 21 | $428 |
| Clotrimazole Generic | 17 | 17 | 13 | $519 |
Brand drugs: - claims; generic drugs: 630 claims; opioid claims: 93.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy M Syperek $2,283 ($2,283 in general payments such as food, travel and fees) from 25 companies. The largest payer was Stryker Corporation with $1,267.
| Company | Payments | Amount |
|---|---|---|
| Stryker Corporation SYK | 84 | $1,267 |
| Amgen Inc. AMGN | 6 | $140 |
| Vertex Pharmaceuticals Incorporated VRTX | 5 | $124 |
| Globus Medical, Inc. GMED | 3 | $90.36 |
| DePuy Synthes Sales Inc. JNJ | 3 | $85.8 |
| Solventum Corporation SOLV | 3 | $74.98 |
| BioWound Solutions, Inc. | 3 | $57 |
| Treace Medical Concepts, Inc. TMCI | 2 | $45.05 |
| Acera Surgical, Inc. | 2 | $40.35 |
| PolyNovo North America LLC | 1 | $39.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.